{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:56:19Z","timestamp":1785444979199,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"VA HSR&D Center for Innovations in Quality, Effectiveness and Safety","award":["CIN 13-413"],"award-info":[{"award-number":["CIN 13-413"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10620-018-5313-z","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:19:11Z","timestamp":1539580751000},"page":"432-438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Proinflammatory Sulfur-Reducing Bacteria Are More Abundant in Colonic Biopsies of Patients with Microscopic Colitis Compared to Healthy Controls"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-7344","authenticated-orcid":false,"given":"Valentine","family":"Millien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"5313_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ajg.2014.431","volume":"110","author":"J Tong","year":"2015","unstructured":"Tong J, Zheng Q, Zhang C, Lo R, Shen J, Ran Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110:265\u2013276. (quiz 277).","journal-title":"Am J Gastroenterol"},{"key":"5313_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/apt.12685","volume":"39","author":"N Nyhlin","year":"2014","unstructured":"Nyhlin N, Wickbom A, Montgomery SM, Tysk C, Bohr J. Long-term prognosis of clinical symptoms and health-related quality of life in microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2014;39:963\u2013972.","journal-title":"Aliment Pharmacol Ther"},{"key":"5313_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3892\/ijmm.2013.1385","volume":"32","author":"M El-Salhy","year":"2013","unstructured":"El-Salhy M, Gundersen D, Hatlebakk JG, Hausken T. Clinical presentation, diagnosis, pathogenesis and treatment options for lymphocytic colitis (Review). Int J Mol Med. 2013;32:263\u2013270.","journal-title":"Int J Mol Med"},{"key":"5313_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gutjnl-2014-308956","volume":"64","author":"H Fischer","year":"2015","unstructured":"Fischer H, Holst E, Karlsson F, et al. Altered microbiota in microscopic colitis. Gut. 2015;64:1185\u20131186.","journal-title":"Gut"},{"key":"5313_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MIB.0b013e31827fec6d","volume":"19","author":"M Rajili\u0107-Stojanovi\u0107","year":"2013","unstructured":"Rajili\u0107-Stojanovi\u0107 M, Shanahan F, Guarner F, de Vos WM. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis. 2013;19:481\u2013488.","journal-title":"Inflamm Bowel Dis"},{"key":"5313_CR6","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1128\/AEM.68.7.3401-3407.2002","volume":"68","author":"EG Zoetendal","year":"2002","unstructured":"Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68:3401\u20133407.","journal-title":"Appl Environ Microbiol"},{"key":"5313_CR7","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10:996\u2013998.","journal-title":"Nat Methods"},{"key":"5313_CR8","doi-asserted-by":"publisher","first-page":"D633","DOI":"10.1093\/nar\/gkt1244","volume":"42","author":"JR Cole","year":"2014","unstructured":"Cole JR, Wang Q, Fish JA, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42:D633\u2013D642.","journal-title":"Nucleic Acids Res"},{"key":"5313_CR9","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590\u2013D596.","journal-title":"Nucleic Acids Res"},{"key":"5313_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335\u2013336.","journal-title":"Nat Methods"},{"key":"5313_CR11","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.","journal-title":"Genome Biol"},{"key":"5313_CR12","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","volume":"53","author":"F Rowan","year":"2010","unstructured":"Rowan F, Docherty NG, Murphy M, Murphy B, Coffey JC, O\u2018Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis Colon Rectum. 2010;53:1530\u20131536.","journal-title":"Dis Colon Rectum"},{"key":"5313_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1574-6941.2002.tb00942.x","volume":"40","author":"J Loubinoux","year":"2002","unstructured":"Loubinoux J, Bronowicki JP, Pereira IA, Mougenel JL, Le Faou AE. Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol. 2002;40:107\u2013112.","journal-title":"FEMS Microbiol Ecol"},{"key":"5313_CR14","doi-asserted-by":"publisher","first-page":"O161","DOI":"10.1111\/codi.12503","volume":"16","author":"G Lennon","year":"2014","unstructured":"Lennon G, Balfe A, Bambury N, et al. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis. Colorectal Dis. 2014;16:O161\u2013O169.","journal-title":"Colorectal Dis"},{"key":"5313_CR15","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/ajg.2010.281","volume":"105","author":"CW Png","year":"2010","unstructured":"Png CW, Lind\u00e9n SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010;105:2420\u20132428.","journal-title":"Am J Gastroenterol"},{"key":"5313_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1128\/AEM.01226-07","volume":"74","author":"M Derrien","year":"2008","unstructured":"Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol. 2008;74:1646\u20131648.","journal-title":"Appl Environ Microbiol"},{"key":"5313_CR17","doi-asserted-by":"publisher","first-page":"e76520","DOI":"10.1371\/journal.pone.0076520","volume":"8","author":"CS Kang","year":"2013","unstructured":"Kang CS, Ban M, Choi EJ, et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE. 2013;8:e76520.","journal-title":"PLoS ONE"},{"key":"5313_CR18","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/AEM.04050-14","volume":"81","author":"J Reunanen","year":"2015","unstructured":"Reunanen J, Kainulainen V, Huuskonen L, et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl Environ Microbiol. 2015;81:3655\u20133662.","journal-title":"Appl Environ Microbiol"},{"key":"5313_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan ME, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65:749\u2013756.","journal-title":"Gut"},{"key":"5313_CR20","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731\u201316736.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5313_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/jgh.12073","volume":"28","author":"T Fujimoto","year":"2013","unstructured":"Fujimoto T, Imaeda H, Takahashi K. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn\u2019s disease. J Gastroenterol Hepatol. 2013;28:613\u2013619.","journal-title":"J Gastroenterol Hepatol"},{"key":"5313_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project, C","year":"2012","unstructured":"Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207\u2013214.","journal-title":"Nature"},{"key":"5313_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.4014\/jmb.1412.12047","volume":"25","author":"G Li","year":"2015","unstructured":"Li G, Yang M, Zhou K, et al. Diversity of duodenal and rectal microbiota in biopsy tissues and luminal contents in healthy volunteers. J Microbiol Biotechnol. 2015;25:1136\u20131145.","journal-title":"J Microbiol Biotechnol"},{"key":"5313_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40168-016-0207-9","volume":"4","author":"E Watt","year":"2016","unstructured":"Watt E, Gemmell MR, Berry S, et al. Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies. Microbiome. 2016;4:61.","journal-title":"Microbiome"},{"key":"5313_CR25","doi-asserted-by":"publisher","first-page":"954051","DOI":"10.4061\/2010\/954051","volume":"2010","author":"GW Tannock","year":"2010","unstructured":"Tannock GW. The bowel microbiota and inflammatory bowel diseases. Int J Inflamm. 2010;2010:954051.","journal-title":"Int J Inflamm"},{"key":"5313_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.05.013","volume":"40","author":"C Huttenhower","year":"2014","unstructured":"Huttenhower C, Kostic AD, Xavier RJ. Inflammatory bowel disease as a model for translating the microbiome. Immunity. 2014;40:843\u2013854.","journal-title":"Immunity"},{"key":"5313_CR27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489\u20131499.","journal-title":"Gastroenterology"},{"key":"5313_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bpg.2013.03.005","volume":"27","author":"D Berry","year":"2013","unstructured":"Berry D, Reinisch W. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases? Best Pract Res Clin Gastroenterol. 2013;27:47\u201358.","journal-title":"Best Pract Res Clin Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5313-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5313-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T19:22:43Z","timestamp":1571080963000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5313-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["5313"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5313-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"assertion":[{"value":"22 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"(1) JH has served as a speaker for AbbVie, Janssen, a consultant for UCB, and served on an advisory board for Pfizer. JH has received research funding from AbbVie, Janssen, Pfizer, Celgene, and RedHill Biopharma. (2) VM, DR, and RS have no financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}